Frederick W. Driscoll

2015 - Flexion Therapeutics

In 2015, Frederick W. Driscoll earned a total compensation of $1.4M as Chief Financial Officer at Flexion Therapeutics, a 59% increase compared to previous year.

Compensation breakdown

Bonus$107,730
Option Awards$916,400
Salary$324,000
Other$24,249
Total$1,372,379

Driscoll received $916.4K in option awards, accounting for 67% of the total pay in 2015.

Driscoll also received $107.7K in bonus, $324K in salary and $24.2K in other compensation.

Rankings

In 2015, Frederick W. Driscoll's compensation ranked 6,417th out of 13,638 executives tracked by ExecPay. In other words, Driscoll earned more than 52.9% of executives.

ClassificationRankingPercentile
All
6,417
out of 13,638
53rd
Division
Manufacturing
2,405
out of 5,190
54th
Major group
Chemicals And Allied Products
871
out of 1,854
53rd
Industry group
Drugs
696
out of 1,528
55th
Industry
Pharmaceutical Preparations
544
out of 1,182
54th
Source: SEC filing on April 28, 2017.

Driscoll's colleagues

We found two more compensation records of executives who worked with Frederick W. Driscoll at Flexion Therapeutics in 2015.

2015

Michael Clayman

Flexion Therapeutics

Chief Executive Officer

2015

Neil Bodick

Flexion Therapeutics

Chief Medical Officer

In-depth

You may also like